Home Insemination Products Market is determined to arrive at $2.4 billion by 2026, expanding at a CAGR of 6.9% during the anticipated timeframe of 2021-2026.
Home insemination is a fertilization technique that contains sperm placed into the female's reproductive tract using a syringe. This method is often suitable for lesbian couples, single women, and infertile couples. Most couples find it difficult when they try to conceive for the first time. These people prefer home insemination to in vitro fertilization (IVF). This procedure is done at home using an insemination kit that includes semen containers, ovulation tests, syringes, and other items to aid conception. Some kits include ovulation prediction kits because the technique is important over time depending on the female menstrual cycle. Home insemination has several advantages, such as partner involvement, a relaxed environment, the use of fresh semen, high pregnancy rates, and the low cost of the procedure. Home insemination is allowed in most countries, but there are certain legalities of insemination that must be observed. However, there are no complete or perfect standards for home insemination. Currently, fertility law is strictly followed in developed countries like the United States and the United Kingdom.
Recent Developments:
In November 2021, Subhag invented the world's first V conceive home intrauterine insemination (IUI) kit to solve the problem of childlessness for infertile couples who do not see doctors or clinics.
In November 2019, the Prime Minister launched the national artificial insemination program and a national workshop in all KrishiVIgyanKendras (KVK) of the 687 districts of the country on vaccination and disease management, artificial insemination, and productivity.
As of September 2021, the Turkey Baster method is the most common form of artificial insemination to get pregnant by artificial insemination at home. Most of the time, he does NOT use a turkey bulb, but a disposable syringe.
In May 2018, Glow is launching a unique new fertility program to help millions of people achieve their dream of starting a family. The largest mobile community for women's health offers a range of resources to help with fertility treatment, including training, affordable prices, funding, and access to world-class fertility clinics.
In October 2016, Baba Ramdev's Patanjali plans to use artificial insemination to produce 92% calves. Artificial insemination will be your weapon, with sperm from Brazilian bulls and technical support from American and Dutch experts.
Market Growth:
The problem of infertility is one of the biggest and most serious concerns in the world that is developing among young people. The female preference for pregnancy and the gradual increase in the number of subfertile couples requiring assistance with pregnancy can be considered as factors for the growth of the market. Age, egg quality in women and also in women around 30 years old is expected to increase the demand for home insemination.
Changing lifestyles with an increasing focus of modern women on planned and reproductive life. Many modern career-oriented women delay motherhood due to an uninterrupted full-time career. This factor is driving the need for a home insemination product that drives the market growth. Further, factors like low cost compared to other fertilization procedures and increase in male infertility cases are the other factors supporting the market demand. However, the market is faced with some challenges such as safety concerns, ethical concerns, and a high risk of transmission of STDs.
Market Drivers:
The use of the home insemination technique has increased in the population as infertility becomes more prevalent, increasing preference of women for pregnancy and rising number of subfertile couples who need help for pregnancy. Conception depends on a number of factors, such as age, quality of eggs, etc., and women in their 30s may find pregnancy to take longer. All of these factors have been attributed to the increased demand for home insemination around the world. The market for home insemination products is driven by the fact that it is a way to help people have children who otherwise could not conceive. In Western countries, many lesbian couples who wish to have a child are also opting for AI. Previously, couples opted for IVF treatment, but now they have realized the cheaper and easier alternative of home insemination at home or in the clinic. Other market drivers are more women choosing to become single mothers, advances in the technology of existing products, new products launched, etc.
Market Restraints:
However, the strict regulations that most countries put in place regarding who can receive fertility treatments are hampering the growth in the size of the global home insemination market. Some countries in Asia and the Middle East have strict family laws and have yet to pass laws on fertility and other related services. Hence, it is supposed to hamper the market growth during the forecast period 2021-2026.
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2021 – 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021-2026 |
|
CAGR |
6.9% |
|
Segments Covered |
By Product By Procedure Type By End-User |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
INVO Bioscience, Medgyn Products, Inc., Fujifilm Irvine Scientific., Kitazato Corporation, Rocket Medical plc, Genea Limited, Vitrolife, Rinovum Women's Health, LLC., and HI-TECH Solutions. |
The intrauterine insemination segment is expected to be the largest type of procedure in the market as it increases the fertilization rate by inserting sperm into a woman's uterus to facilitate fertilization.
Among these, the Insemination Kits segment is estimated to be the fastest-growing in terms of value due to the growing geriatric population and is likely to generate higher revenue during the outlook period.
The fertility centers segment is anticipated to grasps the largest share of the worldwide market during the conjecture period. In addition, the main pharmaceutical companies are working on the launch of new insemination kits with conventional benefits. This is predicted to drive the growth of the global home insemination market.
Regional Analysis:
The market in the United States is expected to register a constant growth rate during the forecast period owing to increasing technological advancements. Additionally, fertility issues are on the rise in the United States, ultimately fueling demand for home insemination in the region. For example, about 13% of women aged 16 to 45 in the United States have trouble getting pregnant.
The European market is anticipated to register a significant growth rate during the outlook period. This can be attributed to the unhealthy lifestyle and the increased prevalence of infertility. In addition, pregnancy delays and lifestyle changes are the major growth factors of the home insemination market in Europe.
The Asia-Pacific market is determined to dominate the home insemination market due to the increasing prevalence of infertility. For example, according to the Asian Pacific Journal of Reproduction, in 2019, in China, the infertility rate is 16% to 25% in women and 11% to 13% in men. Additionally, there is increased awareness of infertility treatment options which is expected to drive the growth of the home insemination market in the region.
The market in the Middle East and Africa is foreseen to grow at a substantial rate due to the increasing rate of infertility in this locale.
Key Players:
The key players operating in the global home insemination market are INVO Bioscience, Medgyn Products, Inc., Fujifilm Irvine Scientific., Kitazato Corporation, Rocket Medical plc, Genea Limited, Vitrolife, Rinovum Women's Health, LLC., and HI-TECH Solutions.
1. Introduction
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferencees
4. Market Dynamics
4.1 Impact Analysis
4.1.1 Drivers
4.1.2 Restaints
4.1.3 Opportunities
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.2 Products/Service
5.1.3 Regional Presence
5.2 Mergers & Acquistion Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 Home Insemination Products Market, By Procedure
6.1.1 Intrauterine Insemination
6.1.2 Intracervical Insemination
6.1.3 Intratubal Insemination
6.1.4 Market Size Estimations & Forecasts (2021-2026)
6.1.5 Y-o-Y Growth Rate Analysis
6.1.6 Market Attractiveness Index
6.2 Home Insemination Products Market, By Product Type
6.2.1 Insemination Kits
6.2.2 Home Conception Devices
6.2.3 Accessories
6.2.4 Market Size Estimations & Forecasts (2021-2026)
6.2.5 Y-o-Y Growth Rate Analysis
6.2.6 Market Attractiveness Index
6.3 Home Insemination Products Market, By End-User
6.3.1 Hospital & Clinics
6.3.2 Fertility Centers
6.3.3 Home Care Settings
6.3.4 Market Size Estimations & Forecasts (2021-2026)
6.3.5 Y-o-Y Growth Rate Analysis
6.3.6 Market Attractiveness Index
7. Geographical Landscape
7.1 Global Identity Governance and Administration Market, by Region
7.2 North America - Market Analysis (2021 - 2026)
7.2.1 By Country
7.2.1.1 USA
7.2.1.2 Canada
7.2.2 By Procedure
7.2.3 By Product Type
7.2.4 By End-User
7.3 Europe
7.3.1 By Country
7.3.1.1 UK
7.3.1.2 France
7.3.1.3 Germany
7.3.1.4 Spain
7.3.1.5 Italy
7.3.1.6 Rest of Europe
7.3.2 By Procedure
7.3.3 By Product Type
7.3.4 By End-User
7.4 Asia Pacific
7.4.1 By Country
7.4.1.1 China
7.4.1.2 India
7.4.1.3 Japan
7.4.1.4 South Korea
7.4.1.5 South East Asia
7.4.1.6 Australia & NZ
7.4.1.7 Rest of Asia-Pacific
7.4.2 By Procedure
7.4.3 By Product Type
7.4.4 By End-User
7.5 Latin America
7.5.1 By Country
7.5.1.1 Brazil
7.5.1.2 Argentina
7.5.1.3 Mexico
7.5.1.4 Rest of Latin America
7.5.2 By Procedure
7.5.3 By Product Type
7.5.4 By End-User
7.6 Middle East and Africa
7.6.1 By Country
7.6.1.1 Middle East
7.6.1.2 Africa
7.6.2 By Procedure
7.6.3 By Product Type
7.6.4 By End-User
8. Key Player Analysis
8.1 INVO Bioscience
8.1.1 Business Description
8.1.2 Products/Service
8.1.3 Financials
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 Medgyn Products, Inc.
8.3 Fujifilm Irvine Scientific
8.4 Kitazato Corporation
8.5 Rocket Medical plc
8.6 Genea Limited
8.7 Vitrolife
8.8 Rinovum Women's Health, LLC
8.9 HI-TECH Solutions
9. Market Outlook & Investment Opportunities
Appendix
List of Tables
List of Figures
